PharmNovo

Lund, Sweden

PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.

$16.3M raised

Jul 2024

Venture - Series Unknown

Top Investors

Almi InvestScietyEIC AcceleratorKarolinskaPolynom Investment

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PharmNovo raised?

PharmNovo has raised $16.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.

Who are PharmNovo's investors?

PharmNovo's investors include Almi Invest, Sciety, EIC Accelerator, Karolinska, Polynom Investment.

Where is PharmNovo headquartered?

PharmNovo is headquartered in Lund, Sweden.

What does PharmNovo do?

PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.

What stage is PharmNovo at?

PharmNovo is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 15, 2024.

MLA

"PharmNovo — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/pharmnovo. Accessed June 4, 2026.

APA

VCBacked. (2024). PharmNovo — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/pharmnovo

Wikipedia (cite web)

{{cite web |title=PharmNovo — Funding & Investors |url=https://www.vcbacked.co/company/pharmnovo |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 15, 2024.